Featured Posts
Study
A Free Market is the Best Medicine
Introduction The pharmaceutical supply market is seeing extraordinarily high levels of innovation and consumer-benefiting evolution. The combination of a competitive market for generic drugs, rapid…
Blog
Congress considers micromanaging PBM finances
With the first reconciliation bill behind it, Congress is now looking to reform other aspects of the health care system. Pharmacy Benefit Manager (PBM)…
Blog
Free the Economy podcast: Drug costs and benefits with Sally Pipes
In this week’s episode we cover reforms to the Endangered Species Act, attacks on US tech firms, nuclear power innovation,…
Search Posts
Citation
Competitive Enterprise Institute Pleased With PDUFA Recommendations
Citation
Think Tank: More FDA 510(k) Oversight Needed, Driving Innovation Overseas
Citation
Competitive Enterprise Institute Criticizes the FDA
Citation
Conservative think tank report blasts FDA
Citation
News Bites: Bachmann’s IPAB Claims Fall Flat
News Release
New Study Reveals Mismanagement of FDA Medical Device Reviews
Washington, D.C., October 12, 2011—The Food and Drug Administration’s 510(k) review process for medical devices has been severely mismanaged by agency officials, according to…